These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6373061)

  • 21. [Statistical interpretation of tests of the stimulation of secretion of growth-hormone by insulin and arginine].
    Job JC; Sizonenko PC; Balage M
    Arch Fr Pediatr; 1971 May; 28(5):505-20. PubMed ID: 5561753
    [No Abstract]   [Full Text] [Related]  

  • 22. Euprolactinemic Galactorrhea. Response of bioassayable prolactin to thyrotropin-releasing hormone.
    Ataya KM; Subramanian MG; Lawson DM; Gala RR
    J Reprod Med; 1996 Mar; 41(3):156-60. PubMed ID: 8778412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunoassay and bioassay of human growth hormone and human prolactin.
    Tanaka T; Shishiba Y; Gout PW; Beer CT; Noble RL; Friesen HG
    J Clin Endocrinol Metab; 1983 Jan; 56(1):18-20. PubMed ID: 6401184
    [No Abstract]   [Full Text] [Related]  

  • 24. Correlative study of radioreceptor assay and radioimmunoassay of serum growth hormone in children. II: Primary, genetic and intra-uterine growth retardation.
    Garnier PE; Repellin AM; Job JC
    Acta Endocrinol (Copenh); 1978 Jun; 88(2):227-38. PubMed ID: 580825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The radioimmunoassay of growth hormone and prolactin and its application].
    Zhang YS; Du JZ; Xu NY; Wu Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2001 May; 17(2):189-91. PubMed ID: 21171417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of serum human growth hormone measurement with NB2 lymphoma cell bioassay, IM-9 receptor modulation assay, and radioimmunoassay in children with disorders of growth.
    Tokuhiro E; Dean HJ; Friesen HG; Rudman D
    J Clin Endocrinol Metab; 1984 Mar; 58(3):549-54. PubMed ID: 6319455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The advantages of combined stimulation by arginine and insulin in the study of the secretion of growth hormone.
    Ruitton A; Tell G; David M; Rocard E
    Rev Eur Etud Clin Biol; 1972 Nov; 17(9):846-54. PubMed ID: 4653986
    [No Abstract]   [Full Text] [Related]  

  • 28. Electrophoretically separable forms of rat prolactin with different bioassay and radioimmunoassay activities.
    Asawaroengchai H; Russell SM; Nicoll CS
    Endocrinology; 1978 Feb; 102(2):407-14. PubMed ID: 743965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between bioassay and radioimmunoassay measurement of prolactin in the IPL rat, a hypoprolactinemic rat strain.
    Cohen H; Sabbagh I; Guillaumot P; Bertrand J; Robertson M; Friesen HG
    Biol Reprod; 1988 Feb; 38(1):84-90. PubMed ID: 3365473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.
    Foster CM; Borondy M; Markovs ME; Hopwood NJ; Kletter GB; Beitins IZ
    Pediatr Res; 1994 Feb; 35(2):218-22. PubMed ID: 7513079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum interleukin 2 (IL-2) levels and prolactin bioactive/radioimmunoassay ratios of women at risk for breast cancer.
    Gala RR; Martino S; Wiejowski SA; Kresge CL; Alonso MM
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1603-5. PubMed ID: 2591452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous stimulation test for the anterior pituitary hormones.
    Voigt KH; Dahlen HG; Fehm HL; Birk J; Schröder K; Schneider HP; Rothenbuchner G; Pfeiffer EF
    Horm Metab Res; 1974 Jul; 6(4):337-8. PubMed ID: 4370373
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of pituitary bioactive prolactin secretion in the male rat by the glucocorticoid agonist decadron phosphate.
    Briski KP; Sylvester PW
    Biol Reprod; 1992 Sep; 47(3):478-84. PubMed ID: 1511101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of RIA kits with polyclonal antiserum and IRMA kits with monoclonal antibodies for the determination of plasma prolactin and somatotropin in patients with pituitary adenoma.
    Oosterom R; Lamberts SW
    J Clin Chem Clin Biochem; 1985 Jan; 23(1):51-4. PubMed ID: 3981090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioactivity of human growth hormone in serum: validation of an in vitro bioassay.
    Foster CM; Borondy M; Padmanabhan V; Schwartz J; Kletter GB; Hopwood NJ; Beitins IZ
    Endocrinology; 1993 May; 132(5):2073-82. PubMed ID: 8477657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Partial growth hormone deficiency: endogenous growth hormone content and effect of exogenously administered human growth hormone].
    Butenandt O
    Klin Wochenschr; 1973 Mar; 51(6):266-71. PubMed ID: 4698393
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulation of growth hormone and prolactin secretion in patients with acromegaly and-or excessive prolactin secretion.
    Cryer PE; Jacobs LS; Daughaday WH
    Mt Sinai J Med; 1973; 40(3):402-13. PubMed ID: 4197309
    [No Abstract]   [Full Text] [Related]  

  • 38. Hamster prolactin: physiological changes in blood and pituitary concentrations as measured by a homologous radioimmunoassay.
    Borer KT; Kelch RP; Corley K
    Neuroendocrinology; 1982; 35(1):13-21. PubMed ID: 7110522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basal prolactin and total lactogenic hormone levels by microbioassay and immunoassay in normal human sera.
    Maddox PR; Jones DL; Mansel RE
    Acta Endocrinol (Copenh); 1991 Dec; 125(6):621-7. PubMed ID: 1789057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower prolactin bioactivity in unmedicated schizophrenic patients.
    Warner MD; Walker AM; D'Souza DC; Lee D; Nasseri D; Peabody CA
    Psychiatry Res; 2001 Jul; 102(3):249-54. PubMed ID: 11440775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.